Why the study?
Does thumb acceleration differ from thenar electromyography in evaluating the neuromuscular blocking properties of alcuronium in ASA physical status I patients?
Does thumb acceleration differ from thenar electromyography in evaluating the neuromuscular blocking properties of alcuronium in ASA physical status I patients?
Clinically significant differences exist between thumb acceleration and thenar EMG when evaluating neuromuscular blocking drugs, highlighting the importance of the assessment method.
Answers are grounded in this paper and cite their sources.
Acc overestimates block depth and duration vs EMG; leaves open optimal monitoring method for alcuronium dosing.
We compared thumb acceleration (Acc) and thenar electromyography (EMG) techniques by evaluating the neuromuscular blocking properties of alcuronium in 14 ASA physical status I patients. The dose-response curves determined by the two techniques were parallel but the EMG-curve was shifted 25% to the right (P less than 0.001). Acc reflected 8-11% greater neuromuscular block than simultaneous EMG in every patients (P less than 0.05). Concurrently, the duration of greater than 90% neuromuscular block maintained by alcuronium 280 micrograms/kg was significantly longer when measured by the Acc transducer (30 vs. 19 min, P less than 0.001). Although the TOF ratios were in good correlation (r2 = 0.82), clinically significant differences existed between the two simultaneous techniques. The results underline the importance of the method of assessment of neuromuscular transmission when evaluating the action of neuromuscular blocking drugs.
No takes yet. Share an insight, caveat, or question.
Meretoja et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: